Irish Life Health

Conor Pope looks at what might happen with interest rates, for borrowers and savers, and whether other bills will rise again

Policy prices to increase by an average of 4.8% from January

Industry watchdog says there are 2.44 million people with insurance, 47.6% of total population

Double increase price ‘shock’ to take effect for Laya customers from October 1st with competitors expected to follow

Insurer has announced two recent price increases citing rising hospital procedure costs

If you have been on the same policy for more than three years you are probably overpaying by about 25%

Public patients may now have to wait up to two years longer than all private patients for access to innovative therapies

Irish Life Health has expressed concerns about the impact of plans to amend regulations for minimum health insurance benefits.

While you may be adept at claiming money back for a GP visit, many of us fail to claim a host of other benefits

Laya Healthcare and Irish Life Health must be unsettled as leading oncologists clearly direct patients to rival VHI

Irish Cancer Society calls for re-examination of ‘whole system’ of drug reimbursement

Two cancer patients and two oncologists raise concerns about how customers of private health insurers Irish Life and Laya Healthcare are losing out on access to new cancer treatments

Irish Life Health points to increase in healthcare claims made post-pandemic as other players weigh up premium hikes

Price rises set to average 5 per cent and will see family policies climb by between €160 and €220

Insurer said it would be contacting its customers in the coming weeks with details

Declan Bolger to take over Irish Life role as David Harney moves to European role

Woman faces €40,000 bill for drug licensed in Ireland but not for her head and neck cancer

Patient’s insurer refuses to cover €40,000 cost of treatment as drug has not been approved for particular cancer

Pharma group says eight cancer therapies awaiting HSE approval for over 900 days